Annemarie Hanekamp has overseen some of the most transformative changes in oncology over her years in Big Pharma. Now, she ...
Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market ...
Moderna (NASDAQ: MRNA) shareholders have been having a rough time lately. The biotech stock rocketed higher last spring, but ...
We recently published a list of 11 Stocks That Will Go to the Moon According to Reddit. In this article, we are going to take ...
22hon MSN
Short interest for healthcare stocks in S&P 500 rose slightly in December vs. November, while Moderna continued to be the most shorted stock of the month. The average short interest for S&P 500 Health ...
The firm noted Moderna's reduced 2024 sales forecast of $3.0–$3.1 billion, down from $3.0–$3.5 billion, driven by declines in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback